Detailed information for compound 1622538

Basic information

Technical information
  • TDR Targets ID: 1622538
  • Name: (5Z)-3-(4,6-dichloro-1,3-benzothiazol-2-yl)-5 -[(4-hydroxy-3-methoxyphenyl)methylidene]-2-p henylimidazol-4-one
  • MW: 496.365 | Formula: C24H15Cl2N3O3S
  • H donors: 1 H acceptors: 3 LogP: 6.39 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cc(ccc1O)/C=C/1\N=C(N(C1=O)c1sc2c(n1)c(Cl)cc(c2)Cl)c1ccccc1
  • InChi: 1S/C24H15Cl2N3O3S/c1-32-19-10-13(7-8-18(19)30)9-17-23(31)29(22(27-17)14-5-3-2-4-6-14)24-28-21-16(26)11-15(25)12-20(21)33-24/h2-12,30H,1H3/b17-9-
  • InChiKey: ZTHXONLHSQWQRH-MFOYZWKCSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 3-(4,6-dichloro-1,3-benzothiazol-2-yl)-5-[(4-hydroxy-3-methoxyphenyl)methylidene]-2-phenylimidazol-4-one
  • 3-(4,6-dichloro-1,3-benzothiazol-2-yl)-5-[(4-hydroxy-3-methoxy-phenyl)methylene]-2-phenyl-imidazol-4-one
  • (5Z)-3-(4,6-dichloro-1,3-benzothiazol-2-yl)-5-[(4-hydroxy-3-methoxy-phenyl)methylene]-2-phenyl-imidazol-4-one
  • 3-(4,6-dichloro-1,3-benzothiazol-2-yl)-5-[(4-hydroxy-3-methoxyphenyl)methylene]-2-phenyl-4-imidazolone
  • (5Z)-3-(4,6-dichloro-1,3-benzothiazol-2-yl)-5-[(4-hydroxy-3-methoxyphenyl)methylene]-2-phenyl-4-imidazolone
  • 3-(4,6-dichloro-1,3-benzothiazol-2-yl)-5-(4-hydroxy-3-methoxy-benzylidene)-2-phenyl-imidazol-4-one
  • (5Z)-3-(4,6-dichloro-1,3-benzothiazol-2-yl)-5-(4-hydroxy-3-methoxy-benzylidene)-2-phenyl-imidazol-4-one
  • 3-(4,6-dichloro-1,3-benzothiazol-2-yl)-5-[(4-hydroxy-3-methoxy-phenyl)methylidene]-2-phenyl-imidazol-4-one
  • (5Z)-3-(4,6-dichloro-1,3-benzothiazol-2-yl)-5-[(4-hydroxy-3-methoxy-phenyl)methylidene]-2-phenyl-imidazol-4-one
  • NCI60_039230
  • NSC711846

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus multilocularis p2X purinoceptor 4 0.1842 1 1
Schistosoma mansoni P2X receptor subunit 0.1842 1 1
Echinococcus granulosus p2X purinoceptor 4 0.1842 1 1
Trypanosoma cruzi hypothetical protein, conserved 0.064 0.1069 0.5
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.0647 0.1118 0.0055
Brugia malayi Trypsin family protein 0.0647 0.1118 1
Plasmodium vivax cysteine repeat modular protein 1, putative 0.064 0.1069 0.5
Plasmodium falciparum cysteine repeat modular protein 1 0.064 0.1069 0.5
Toxoplasma gondii PAN domain-containing protein 0.1272 0.5768 1
Loa Loa (eye worm) hypothetical protein 0.0647 0.1118 1
Schistosoma mansoni P2X receptor subunit 0.1842 1 1
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.0647 0.1118 0.0055
Leishmania major hypothetical protein, conserved 0.064 0.1069 0.5
Schistosoma mansoni P2X receptor subunit 0.1842 1 1
Echinococcus multilocularis p2X purinoceptor 4 0.1842 1 1
Loa Loa (eye worm) hypothetical protein 0.0647 0.1118 1
Echinococcus granulosus p2X purinoceptor 4 0.1842 1 1
Onchocerca volvulus 0.0647 0.1118 1
Echinococcus multilocularis p2X purinoceptor 4 0.1842 1 1
Onchocerca volvulus 0.064 0.1069 0.9558
Schistosoma mansoni P2X receptor subunit 0.1842 1 1
Toxoplasma gondii PAN domain-containing protein 0.1272 0.5768 1

Activities

Activity type Activity value Assay description Source Reference
GI50 (functional) -4.789 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.674 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.672 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.654 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.611 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.588 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.568 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.458 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.381 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.